Graham-Pole J - Search Results

1

Response of osteogenic sarcoma to the combination of etoposide and cyclophosphamide as neoadjuvant chemotherapy.

Saleh RA, Graham-Pole J, Cassano W, Abbot F, Vander Griend R, Dickson N, Metha P, Heare M, Kedar A, Heare T, et al. Saleh RA, et al. Cancer. 1990 Feb 15;65(4):861-5. doi: 10.1002/1097-0142(19900215)65:4<861::aid-cncr2820650405>3.0.co;2-h. Cancer. 1990. PMID: 2297654

2

Etoposide, cyclophosphamide, cisplatin, and doxorubicin as neoadjuvant chemotherapy for osteosarcoma.

Cassano WF, Graham-Pole J, Dickson N. Cassano WF, et al. Cancer. 1991 Nov 1;68(9):1899-902. doi: 10.1002/1097-0142(19911101)68:9<1899::aid-cncr2820680909>3.0.co;2-x. Cancer. 1991. PMID: 1913541

3

Late follow-up of a short-term intensive regimen for Ewing's sarcoma.

Marcus RB Jr, Springfield DS, Graham-Pole JR, Heare TC, Enneking WF, Million RR. Marcus RB Jr, et al. Am J Clin Oncol. 1991 Oct;14(5):446-50. doi: 10.1097/00000421-199110000-00017. Am J Clin Oncol. 1991. PMID: 1951181

4

High-dose chemotherapy with marrow reinfusion and hyperfractionated irradiation for children with high-risk brain tumors.

Kedar A, Maria BL, Graham-Pole J, Ringdahl DM, Quisling RG, Mickle JP, Mendenhall NP, Marcus RB Jr, Gross S. Kedar A, et al. Med Pediatr Oncol. 1994;23(5):428-36. doi: 10.1002/mpo.2950230507. Med Pediatr Oncol. 1994. PMID: 8084310 Clinical Trial.

5

Neoadjuvant chemotherapy for patients with osteosarcoma: University of Florida studies.

Graham-Pole J, Ayass M, Cassano W, Dickson N, Enneking W, Heare M, Heare T, Marcus R, Saleh R, Spanier S. Graham-Pole J, et al. Cancer Treat Res. 1993;62:339-46. doi: 10.1007/978-1-4615-3518-8_41. Cancer Treat Res. 1993. PMID: 8096749 Review. No abstract available.

6

Local control and function after twice-a-day radiotherapy for Ewing's sarcoma of bone.

Marcus RB Jr, Cantor A, Heare TC, Graham-Pole J, Mendenhall NP, Million RR. Marcus RB Jr, et al. Int J Radiat Oncol Biol Phys. 1991 Nov;21(6):1509-15. doi: 10.1016/0360-3016(91)90326-y. Int J Radiat Oncol Biol Phys. 1991. PMID: 1938560

7

Severe hyperphosphatemia associated with tumor lysis in a patient with T-cell leukemia.

Saleh RA, Graham-Pole J, Cumming WA. Saleh RA, et al. Pediatr Emerg Care. 1989 Dec;5(4):231-3. doi: 10.1097/00006565-198912000-00008. Pediatr Emerg Care. 1989. PMID: 2602196

8

Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature.

Mehta P, Kedar A, Graham-Pole J, Skoda-Smith S, Wingard JR. Mehta P, et al. Pediatrics. 1999 Apr;103(4):e44. doi: 10.1542/peds.103.4.e44. Pediatrics. 1999. PMID: 10103336 Review.

9

Increased clearance of tacrolimus in children: need for higher doses and earlier initiation prior to bone marrow transplantation.

Mehta P, Beltz S, Kedar A, Graham-Pole J, Wingard JR. Mehta P, et al. Bone Marrow Transplant. 1999 Dec;24(12):1323-7. doi: 10.1038/sj.bmt.1702053. Bone Marrow Transplant. 1999. PMID: 10627642 Clinical Trial.

10

Pulmonary function tests after whole-lung irradiation and doxorubicin in patients with osteogenic sarcoma.

Ellis ER, Marcus RB Jr, Cicale MJ, Springfield DS, Bova FJ, Graham-Pole J, Enneking WF, Spanier SS, Million RR. Ellis ER, et al. J Clin Oncol. 1992 Mar;10(3):459-63. doi: 10.1200/JCO.1992.10.3.459. J Clin Oncol. 1992. PMID: 1740684

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters